CARDIOVASCULAR
DISORDERS
                       Prepared by: Vinz Tomboc, RN
TOPRANK | Nursing
                         BASIC CONCEPTS
      Cardiovascular Function:
      Heart -
      •     Diastole -
      •     Systole -
      •     Chambers: ____
      •     Valves: ____
      •     __________ - amount of blood ejected per contraction
            • Cardiac Output = ___ x ___ → per minute
TOPRANK | Nursing
                      BASIC CONCEPTS
      Auscultation Landmarks
      1. All -
      2. People -
      3. Enjoy -
      4. Time -
      5. Magazine -
TOPRANK | Nursing
                             BASIC CONCEPTS
      Risk Factors
      • Modifiable
         • _______ control
            •       alcohol, smoking, diet, physical inactivity, obesity, hypertension,
                    hyperlipidemia, diabetes mellitus
      •     Non-modifiable
            • _______ control
            • age, gender, family history, race
      #1 Cause of Death in the Philippines: ____________
TOPRANK | Nursing
                       HYPERTENSION
      Definition:
      • Strongest risk factor: ___________
      Diagnosis
      • Systolic BP (SBP): _______     Diastolic BP (DPB): _______
         • # of readings: _____ on ___________
      • Position → Feet: ___________ Arm Level: ___________
      •     Errors:
            • Too Tight: _________
            • Too Loose: ___________
TOPRANK | Nursing
                               HYPERTENSION
      Diagnosis
      • Patient Teaching:
         • NO ___________ for at least ______
            •       Activity: ___________ for at least ______
      Masked vs White Coat:
      • _______________
            •       Home BP: High                 Clinic BP: Normal
      •     _______________
            • Home BP: Normal                     Clinic BP: High
TOPRANK | Nursing
                          HYPERTENSION
      Stages:
                                    SBP            DPB
                      Normal
                     Elevated
                    Stage 1 HTN
                    Stage 2 HTN
      Types:
      •     Primary/Essential
            • Incidence: ________     Cause: ___________
      •     Secondary
            • Incidence: ________     Cause: ___________
TOPRANK | Nursing
                    HYPERTENSION
TOPRANK | Nursing
                               HYPERTENSION
      Management
      Goal: ___________ → WOF: ___________
      Initial: __________
      • BMI: __________
      • AVOID: ___________
      • Diet: __________
            •       Na: _____
            •       K: _____
            •       Fat: _____
            •       Fruits, Vegetables: _____
TOPRANK | Nursing
                      HYPERTENSION
      Management
      BP (>140/90) after 1-3 months: __________
      • ACE Inhibitors, ARBs →
TOPRANK | Nursing
                              HYPERTENSION
      Management
      • ACE Inhibitors - “-______” →
        • Prototype: __________
            •       A/E:
                    • A - _________ → Priority: _________ → NI: _________
                    • C - _________ → NI: _________
                    • E - _________ → Diet: _________
              • D - _________ → Risk for: _________ → Monitor: _________
      •     Angiotensin Receptor Blockers (ARBs) - “-______” →
            • Prototype: __________
            • CI: __________→ Women of Child-Bearing Age: _________
TOPRANK | Nursing
                    HYPERTENSION
      Sympathetic Receptors
TOPRANK | Nursing
                             HYPERTENSION
      Management
      • α-1 Blocker - “-______” →
        • Prototype: __________
            •       NOT: __________ → Risk for: __________
      •     α-2 Agonists →
            • Prototypes: __________, __________
            •       DO NOT: __________ → Risk for: __________
            •       Not given with: __________
TOPRANK | Nursing
                              HYPERTENSION
      Management
      • β-Blockers - “-______” →
        • Prototype: __________
            •       Administer: __________
            •       HOLD:
                    • B–
                    • B–
                    • B–
                    • B–
            •       Antidote: __________
TOPRANK | Nursing
                              HYPERTENSION
      Management
      • Calcium Channel Blockers
            •       Dihydropyridines: “-______” - __________
                    • S/E: __________ → Common: __________
            •       Non-Dihydropyridines: __________, __________
                    • S/E: __________
            •       AVOID: __________          Not given with: __________
TOPRANK | Nursing
                              HYPERTENSION
      Management
      Diuretics
      • Administration: __________
      •     Thiazide -
            • Prototype: __________
            •       Electrolyte: __________ → Diet: __________
            •       Blood Sugar: __________ → Monitor: __________
            •       Eyes, Skin: __________ → Wear: __________
TOPRANK | Nursing
                              HYPERTENSION
      Diuretics
      • Loop diuretics -
         • Prototype: _________ → CI: _________ → Affix: “-_____”, “-_____”
            •       Electrolyte: __________ → Diet: __________
            •       Hearing: __________ → Push: __________
            •       “UO is not increasing within 5-20 mins”
      •     K-sparing -
            • Prototype: __________
            • AE: __________ → Diet: __________
            • CI: __________ → Severe __________
TOPRANK | Nursing
                     HYPERTENSION
      Hypertensive Crisis
      • BP → SBP: ______ DBP: ______
      • Cause: __________
      Types:
      • Hypertensive Urgency -
      • Hypertensive Emergency -
      Clinical Manifestations:
      • Headache: __________       Vision: __________
      • Nose: __________           LOC: __________, __________
TOPRANK | Nursing
                     HYPERTENSION
      Hypertensive Crisis
      Monitoring: __________
      Treatment: __________
      • Potent Vasodilator: __________
      • Calcium Channel Blocker: __________
      • β-Blockers: __________
      Goal: __________
      • Lower BP by: __________
      • STOP at: __________
TOPRANK | Nursing
                    CORONARY CIRCULATION
      Coronary Circulation: Aorta → Phase: __________→
      • Right Coronary Artery →
        • Posterior Descending Artery →__________, __________
      •     Left Coronary Artery →
            • Left Anterior Descending Artery → __________
            • Circumflex Artery → __________
      Coronary Artery Disease
TOPRANK | Nursing
       CORONARY ARTERY DISEASES
      •     Arteriosclerosis -                Ischemia -
      •     Atheroma -                        Infarction -
      •     Atherosclerosis -
      Diseases:
      • Plaque + Exertion → __________
      • Plaque + Clot →
            • Partial → NO Damage→ __________
                        With Damage → Subendocardial → __________
            • Complete → With Damage → Transmural → __________
      •     Vasospasms → __________
TOPRANK | Nursing
       CORONARY ARTERY DISEASES
      Coronary Arteries →
                    Angina Pectoris          Myocardial Infarction
      S                                S
      A                                A
      V                                V
      E                                O
      R                                U
      S                                G
      E__________              E__________     E__________           E__________
TOPRANK | Nursing
                                      ANGINA
      Types:
      • Stable (Exertional) Angina -
        • Rest, NTG: __________              Pattern: __________
            •       Duration: __________
      •     Unstable (Pre-infarction) Angina -
            • Rest, NTG: __________            Pattern: __________
            •       Duration: __________
      •     Prinzmetal Angina - _______________ → ECG changes: ___________
      •     Intractable → ___________ to interventions
TOPRANK | Nursing
                                   ANGINA
      Diagnostics:
      • Troponin, cardiac enzymes: __________
      •     ECG: __________, __________
      •     Cardiac Catheterization (Coronary Angiography): __________
      •     Lipid Profile: __________
      •     Stress Testing: __________, __________
TOPRANK | Nursing
            CARDIAC CATHETERIZATION
      Anesthesia: __________
      Sedation: __________
      Most common site: __________ → __________
                    Pre-procedure:
                    • Priority Assessment: __________, __________
                    • Renal Function: __________, __________
                    •   Withhold: __________, __________
                    •   Diet: __________
                    •   Teaching: __________, _________
TOPRANK | Nursing
            CARDIAC CATHETERIZATION
      Post-procedure
      • Preventing Bleeding
        • Activity: ________               Legs: __________
            • Puncture Site: __________
      •     Perfusion:
            • Assessment: __________
      Discharged
      • Ambulation                    Tub Baths
      • Heavy Lifting                 Bending at waist
      • “Bleeding, swelling, fever, bruising, pain”
TOPRANK | Nursing
                           LIPID PROFILE
      Lipid Values:
      • Cholesterol: __________
      • Triglycerides: __________
      •     Low Density Lipoprotein (LDL): __________
      •     High Density Lipoprotein (HDL): __________
      •     Teaching: __________
      Treatment for Hyperlipidemia: ___________
      • Taken: __________
      • A/E: __________ → NI: __________
      • WOF: __________ → Assessment: __________
TOPRANK | Nursing
                       STRESS TESTING
      Types:
      • Exercise (physical) stress testing -
      • Pharmacological (chemical) stress test -
      Night Prior: __________
      AVOID:
      •     False (+): __________
      •     False (-): __________
      “Chest pain, ST changes”
TOPRANK | Nursing
                                ANGINA
      Management
      Goal: __________, __________
      Nitroglycerin -
      •     S/E: __________
      •     A/E: __________ → NI: __________
      •     STOP: __________
      •     CI: __________
TOPRANK | Nursing
                         ANGINA
      Sublingual NTG -
      S
      S
      S
TOPRANK | Nursing
                                 ANGINA
      NTG Patch (Transdermal)
      • ____ patch at a time, ____ daily
      • Max: __________
      •     Location: __________
            • Most common: __________
            • Area: __________, __________, __________
      •     Shower
      •     MRI
      •     Nurses: __________
TOPRANK | Nursing
                                ANGINA
      Management
      • β-Blockers →
      • Calcium Channel Blocker →
      •     Antiplatelet →
            • Prototype: __________
            • A/E: __________, __________         CI: __________
      •     Anticoagulants →
      Nursing Interventions
      • Position: __________       Activity: __________
      • Administer: __________     Assess: __________ → __________
TOPRANK | Nursing
                    MYOCARDIAL INFARCTION
      Definition:
      • #1 Complication: __________
      Diagnostic Tests:
      • Cardiac Biomarkers
         • Troponin I/T                      CK-MB                    Myoglobin
      • WBC, ESR, CRP: ___                   Cardiac Catheterization: __________
      •     ECG - quickest test for MI → Zone Of:
            • Ischemia: ________
            • Injury: ________
            • Necrosis: ________
TOPRANK | Nursing
                    MYOCARDIAL INFARCTION
TOPRANK | Nursing
                    MYOCARDIAL INFARCTION
      Management
      • M__________
        • WOF: __________                      Antidote: __________
      •     O__________ → Independent: __________
      •     N__________ → Route: __________
      •     A__________
            • Given w/in: __________     Alternative: __________
      •     Thrombolytics:
            • Prototype: U__________, S__________, A__________
            • Given w/in: __________
            • WOF: __________        Antidote: ________
TOPRANK | Nursing
                    MYOCARDIAL INFARCTION
      Management
      • Position: __________
      • Diet:
            • Na/Fluids: ___             Cholesterol: ___
            • Portion: __________
            • AVOID: __________
      •     Activity: __________
            • Elimination: __________
            • Resume SEX:__________
      •     AVOID: __________
            • Usual Cause: __________ → Drug: __________
TOPRANK | Nursing
                    MYOCARDIAL INFARCTION
      Surgery
      • Angioplasty
      •     Atherectomy
      •     CABG
TOPRANK | Nursing
                     HEART FAILURE
      Definition:
      Right Sided (Backward) HF
      Hemodynamic Monitoring: __________
TOPRANK | Nursing
                     HEART FAILURE
      Left Sided (Forward) HF
      Hemodynamic Monitoring: __________
TOPRANK | Nursing
                       HEART FAILURE
      Diagnostics
      • Human B-Natriuretic Peptide (hBNP) - Confirms HF - __________
         • Normal Value: __________
      •     2D echo - Confirms HF - __________
            • EF: ______
      •     CXR - _____________, _____________
      Echocardiogram
      • Transthoracic Echocardiogram -
        • Teaching: __________
        • Intra-procedure Position: __________
TOPRANK | Nursing
                              HEART FAILURE
      Echocardiogram
      • Transesophageal Echocardiogram
        • Pre-procedure
                    • NPO: __________
                    • Sedation: __________
                    • Anesthesia: __________
            •       Intra-procedure Position: __________, __________
            •       Post-procedure
                    • Priority: __________
                    • Position: __________
                    • Throat Soreness: __________
TOPRANK | Nursing
                              HEART FAILURE
      Management
      Goal: __Preload            __Afterload                       __Contractility
      • ACE Inhibitors and ARBS →
      •     β-blockers →
      •     Diuretic →
      •     Digoxin -
            • ___ Inotropic -
                    • Stroke Volume: _______
            •       ___ Chronotropic -         ___ Dromotropic -
                    • 1st Assessment: ________
TOPRANK | Nursing
                              HEART FAILURE
      Management
      • Digoxin
        • Toxicity: __________ → Administer: __________
                    •   N__________
                    •   A__________
                    •   V______________ → __________, __________
                    •   D__________
               • A__________
            • Antidote: __________ K: __________         AVOID: __________
      •     Dilators →
      •     Dopamine, Dobutamine →
TOPRANK | Nursing
                             HEART FAILURE
      Nursing Interventions
      • Priority: __________
      • Monitoring:
            •       Daily Weights
                    • ______ per day or ______ per week
            •       UO: ______
            •       “Edema, Weight gain”
            • “SOB, Crackles, Pink Frothy Sputum”
      •     Position:
            • HOB: __________
            • Legs: __________
TOPRANK | Nursing
                              HEART FAILURE
      Nursing Interventions
      • Diet:
        • Na: ______ → ______
            • Fluid: ______ → ______ → Thirsty: __________
            • Cholesterol: ______
      •     Activity:
            • Rest -
            •       Activity -
                    • “Fatigue, dyspnea, chest pain”
      •     AVOID: __________
TOPRANK | Nursing
TOPRANK | Nursing